In Person Seminar: Cognitive Bias Modification in the Treatment of Addiction: Efficacy and New Insights into Working Mechanisms
Reinout Wiers, Ph.D.
Professor
Department of Psychopathology
University of Amsterdam
Pioneers in Biomedical Research Seminar: Cognitive Bias Modification in the Treatment of Addiction: Efficacy and New Insights into Working Mechanisms
About this Seminar
Varieties of Cognitive Bias Modification (CBM) have been developed and tested in addiction, with evidence of efficacy when added to the treatment of alcohol use disorders across clinical trials. Originally, these interventions were based on dual process models of addiction, with the assumption that CBM would impact associative (automatically activated cognitive-motivational) processes, while traditional therapy would impact reflective processes. However, basic research has undermined this perspective, leading to the development of a new propositional variety of CBM, ABC training (Wiers et al., 2020), which Dr. Wiers will describe and present first data on.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Addiction Recovery Research Center and the Center for Health Behaviors Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Policies to Reduce Ultra-processed Foods: Lessons From Around the Globe , homeJan. 30, 2026, 11:00 a.m. | Lindsey Smith Taillie, Ph.D., MPH, Associate Professor of Nutrition, Associate Chair of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center
-
Home Item
AI and Agentic AI: Opportunities for How We Work, Care, Discover, and Share , homeFeb. 5, 2026, 5:30 p.m. (Reception at 5 p.m.) | Vivian S. Lee, M.D., Ph.D., M.B.A., Executive Fellow, Harvard Business School; Senior Lecturer, Harvard Medical School; Elected Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home Item
Early Childhood Brain Development and Risk for Schizophrenia , homeFeb. 13, 2026, 11 a.m. | John Gilmore, M.D., Eure Distinguished Professor and Vice Chair for Research, Department of Psychiatry, University of North Carolina School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home Item
Is It What You Eat or When You Eat? Evidence for Time Restricted Eating in Humans , homeFeb. 27, 2026, 11:00 a.m. | Lisa Chow, M.D., Professor of Medicine, Pennock Family Land Grant Chair in Diabetes Research, University of Minnesota | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home Item
A Nicotine-Focused Regulatory Strategy: The Science , homeMarch 13, 2026, 11:00 a.m. | Dorothy Hatsukami, Ph.D., Professor of Psychiatry and Behavioral Sciences and Forster Family Chair in Cancer Prevention, Masonic Cancer Center, University of Minnesota | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
From BDNF to Rett Syndrome: Synapses, Networks, and Social Behaviors in Mecp2 Mutant Mice , homeMarch 27, 2026, 11:00 a.m. | Lucas Pozzo-Miller, Ph.D., Mall Family Endowed Professor for Genetic Autism Research, Department of Pediatrics & Human Development, College of Medicine, Michigan State University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research